vs
Side-by-side financial comparison of FrontView REIT, Inc. (FVR) and KORU Medical Systems, Inc. (KRMD). Click either name above to swap in a different company.
KORU Medical Systems, Inc. is the larger business by last-quarter revenue ($11.8B vs $18.2M, roughly 646.9× FrontView REIT, Inc.). On growth, KORU Medical Systems, Inc. posted the faster year-over-year revenue change (22.1% vs 12.0%).
KORU Medical Systems, Inc. is a specialized medical technology company that designs, manufactures, and distributes innovative ambulatory infusion systems and supporting disposable products. It caters to healthcare providers and patients across home care, clinical trial, and acute care segments worldwide, with a focus on enhancing the safety and comfort of specialty medication delivery.
FVR vs KRMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.2M | $11.8B |
| Net Profit | $400.0K | — |
| Gross Margin | — | 61.5% |
| Operating Margin | 24.9% | 31.2% |
| Net Margin | 2.2% | — |
| Revenue YoY | 12.0% | 22.1% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.2M | $11.8B | ||
| Q4 25 | $16.5M | $10.9M | ||
| Q3 25 | $16.8M | $10.4M | ||
| Q2 25 | $17.6M | $10.2M | ||
| Q1 25 | $16.2M | $9.6M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | $14.5M | $8.2M | ||
| Q2 24 | — | $8.4M |
| Q1 26 | $400.0K | — | ||
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $4.0M | $-778.0K | ||
| Q2 25 | $-2.9M | $-206.9K | ||
| Q1 25 | $-833.0K | $-1.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.4M | $-1.6M | ||
| Q2 24 | — | $-988.7K |
| Q1 26 | — | 61.5% | ||
| Q4 25 | — | 62.6% | ||
| Q3 25 | — | 60.2% | ||
| Q2 25 | — | 63.5% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 62.9% | ||
| Q3 24 | — | 63.4% | ||
| Q2 24 | — | 65.0% |
| Q1 26 | 24.9% | 31.2% | ||
| Q4 25 | — | -5.0% | ||
| Q3 25 | — | -8.3% | ||
| Q2 25 | — | -3.1% | ||
| Q1 25 | — | -12.9% | ||
| Q4 24 | — | -18.0% | ||
| Q3 24 | — | -20.8% | ||
| Q2 24 | — | -14.1% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | -24.9% | — | ||
| Q3 25 | 23.9% | -7.5% | ||
| Q2 25 | -16.5% | -2.0% | ||
| Q1 25 | -5.1% | -12.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -16.7% | -19.3% | ||
| Q2 24 | — | -11.7% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.19 | $-0.11 | ||
| Q3 25 | $0.19 | $0.02 | ||
| Q2 25 | $-0.16 | $0.00 | ||
| Q1 25 | $-0.06 | $0.03 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.3M | $8.8B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $514.2M | — |
| Total Assets | $869.8M | $28.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $9.3M | $8.8B | ||
| Q4 25 | $13.5M | $8.9M | ||
| Q3 25 | $19.6M | $8.5M | ||
| Q2 25 | $8.4M | $8.1M | ||
| Q1 25 | $3.3M | $8.7M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | — | $8.8M | ||
| Q2 24 | — | $10.5M |
| Q1 26 | — | — | ||
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $514.2M | — | ||
| Q4 25 | $391.2M | $17.0M | ||
| Q3 25 | $385.2M | $16.5M | ||
| Q2 25 | $369.9M | $16.5M | ||
| Q1 25 | $324.7M | $16.3M | ||
| Q4 24 | — | $16.8M | ||
| Q3 24 | $1.0K | $17.7M | ||
| Q2 24 | — | $18.7M |
| Q1 26 | $869.8M | $28.6B | ||
| Q4 25 | $854.4M | $28.2M | ||
| Q3 25 | $846.8M | $27.1M | ||
| Q2 25 | $856.5M | $25.5M | ||
| Q1 25 | $860.8M | $27.2M | ||
| Q4 24 | — | $27.2M | ||
| Q3 24 | $1.0K | $27.4M | ||
| Q2 24 | — | $27.3M |
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
